What is the significance of high proinsulin levels with low glucose levels and normal insulin and C-peptide (Connecting Peptide) levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

High Proinsulin with Low Glucose and Normal Insulin/C-peptide: Diagnostic Significance

The most likely explanation for high proinsulin with low glucose levels and normal insulin and C-peptide levels is an islet cell tumor (insulinoma) or nesidioblastosis, which causes inappropriate proinsulin secretion leading to hypoglycemia. 1

Pathophysiology and Diagnostic Significance

  • The persistence of inappropriately increased plasma insulin concentrations with low glucose concentration strongly suggests the presence of an islet cell tumor 1
  • An increase in the ratio of fasting proinsulin to insulin in an individual with hypoglycemia is particularly suggestive of an islet cell tumor 1
  • Proinsulin levels above 5 pmol/L with blood glucose levels below 2.5 mmol/L during a 72-hour fast test represent the best criterion for diagnosing endogenous hyperinsulinism, with 100% diagnostic specificity and sensitivity 2
  • Normal C-peptide levels with elevated proinsulin may indicate a defect in the conversion of proinsulin to insulin, which can occur in certain islet cell tumors 1

Differential Diagnosis

1. Insulinoma

  • Insulinomas are characterized by inappropriate insulin secretion with elevated proinsulin levels 3
  • The diagnostic triad (Whipple's triad) includes:
    • Symptomatic hypoglycemia
    • Low blood glucose (<55 mg/dL)
    • Resolution of symptoms after glucose administration 3
  • Insulinomas typically show elevated C-peptide levels (>0.2 nmol/L) with blood glucose below 2.5 mmol/L 2

2. Nesidioblastosis

  • Adult-onset nesidioblastosis presents with hyperinsulinemic hypoglycemia without a discrete tumor 4
  • Unlike insulinomas, C-peptide levels may not be consistently elevated in nesidioblastosis when glucose is below 2.5 mmol/L 2
  • Diagnosis is challenging and often requires extensive testing to rule out insulinoma 4

3. Genetic Disorders

  • Genetic abnormalities that result in the inability to convert proinsulin to insulin can be inherited in an autosomal dominant pattern 1
  • These conditions typically present with mild glucose intolerance rather than hypoglycemia 1
  • Mutations in proinsulin processing enzymes can lead to high proinsulin with normal insulin levels 1

4. Surreptitious Insulin Administration

  • This can be ruled out by measuring C-peptide, which would be low or suppressed with exogenous insulin administration 1, 5
  • Normal C-peptide levels in this case indicate endogenous insulin production 5

Diagnostic Approach

  1. Confirm Hypoglycemia with Inappropriate Insulin/Proinsulin Secretion

    • Perform a 72-hour supervised fast with measurements of:
      • Blood glucose
      • Insulin
      • C-peptide
      • Proinsulin 3, 2
    • Test for sulfonylureas in the urine to rule out factitious hypoglycemia 3
  2. Imaging Studies

    • If endogenous hyperinsulinism is confirmed, proceed with pancreatic imaging:
      • CT or MRI scans
      • Consider endoscopic ultrasound (82% sensitivity for localizing insulinomas) 3
  3. Additional Testing

    • Measure the proinsulin-to-insulin ratio, which is typically elevated in insulinomas 1
    • Consider selective arterial calcium stimulation with hepatic venous sampling if conventional imaging is negative 3

Management Considerations

  • Surgical treatment is recommended for localized insulinomas, with a cure rate of approximately 90% 3
  • Preoperative stabilization of blood glucose through dietary measures and/or diazoxide may be necessary 3
  • For nesidioblastosis or unresectable tumors, diazoxide therapy can be an effective and safe alternative 4
  • Caution is advised when using somatostatin analogs due to potential worsening of hypoglycemia 3

Important Clinical Pearls

  • The absence of changes in glucose, insulin, and proinsulin concentrations in an individual with fasting hypoglycemia makes the diagnosis of an islet cell tumor unlikely 1
  • Measurement of C-peptide is essential in investigating nondiabetic hypoglycemia to rule out hypoglycemia due to surreptitious insulin administration 1, 5
  • Hyperinsulinemia of insulinoma and selected cases of functional hypoglycemia are associated with a greater percentage of proinsulin compared to normal 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic and Management of Hyperinsulinism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

C-peptide Testing for Type 1 Diabetes Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Proinsulin and C-peptide: a review.

Metabolism: clinical and experimental, 1977

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.